爱尔眼科(300015) - 2016 Q1 - 季度业绩预告

Financial Performance Expectations - The company expects a net profit attributable to shareholders of approximately 12,285.48 million yuan for Q1 2016[3] - The estimated net profit growth is projected to be between 30% and 40% compared to the same period last year[3] - The net profit attributable to the listed company is expected to be around 11,407.94 million yuan, up from 8,775.34 million yuan in the previous year[3] - The increase in performance is attributed to the rising brand influence and expansion of operational scale[5] - The impact of non-recurring gains and losses on net profit is estimated to be around -3 million yuan[6] Financial Reporting and Auditing - The performance forecast has not been audited by a registered accountant[4] - The company emphasizes that the financial data will be detailed in the Q1 2016 report[7] - The performance forecast is based on preliminary calculations by the company's finance department[7] Investor Guidance - The main business revenue is expected to maintain stable growth during the reporting period[5] - The company advises investors to make rational investments and be aware of risks[7]